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Abstract
Background: The PWWP domain was first identified as a structural motif of 100–130 amino acids in the WHSC1 protein and
predicted to be a protein-protein interaction domain. It belongs to the Tudor domain ‘Royal Family’, which consists of
Tudor, chromodomain, MBT and PWWP domains. While Tudor, chromodomain and MBT domains have long been known to
bind methylated histones, PWWP was shown to exhibit histone binding ability only until recently.
Methodology/Principal Findings: The PWWP domain has been shown to be a DNA binding domain, but sequence analysis
and previous structural studies show that the PWWP domain exhibits significant similarity to other ‘Royal Family’ members,
implying that the PWWP domain has the potential to bind histones. In order to further explore the function of the PWWP
domain, we used the protein family approach to determine the crystal structures of the PWWP domains from seven
different human proteins. Our fluorescence polarization binding studies show that PWWP domains have weak histone
binding ability, which is also confirmed by our NMR titration experiments. Furthermore, we determined the crystal
structures of the BRPF1 PWWP domain in complex with H3K36me3, and HDGF2 PWWP domain in complex with H3K79me3
and H4K20me3.
Conclusions: PWWP proteins constitute a new family of methyl lysine histone binders. The PWWP domain consists of three
motifs: a canonical b-barrel core, an insertion motif between the second and third b-strands and a C-terminal a-helix bundle.
Both the canonical b-barrel core and the insertion motif are directly involved in histone binding. The PWWP domain has
been previously shown to be a DNA binding domain. Therefore, the PWWP domain exhibits dual functions: binding both
DNA and methyllysine histones.
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Introduction
The PWWP domain was first identified as a structural motif of
100–130 amino acids in the WHSC1 (Wolf-Hirschhorn syndrome
candidate 1) protein and named after the conserved motif Pro-Trp-
Trp-Pro in WHSC1. It was predicted to be a protein-protein
interaction domain [1]. Indeed, the PWWP domain of the DNA
methyltransferase DNMT3A directly binds SALL3, which func-
tions as an inhibitory factor for DNMT3A. SALL3 expression
reduces DNMT3A-mediated CpG islandmethylation incell culture
and in vitro [2]. A mutation in the PWWP domain of DNMT3B
diminishes its interaction with the SUMO E3 ligase PIAS1 [3].
The PWWP domain was later on shown to bind DNA in 2002
by Cheng’s laboratory [4]. The PWWP domains of the DNA
methyltransfearses DNMT3A and DNMT3B are essential for
targeting DNA methylation to heterochromatin regions through
their chromatin binding ability [5,6]. HDGF (hepatoma-derived
growth factor) and the HRPs (HDGF-related proteins) consist of a
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2highly conserved PWWP domain in their N-terminus and a
variable region in the C-terminus. PWWP domains in this
subfamily of PWWP-containing proteins also exhibit DNA binding
ability and some of these HDGF proteins are implicated in
development [7]. HDGF exerts its transcription repressive effect
through binding to a conserved DNA element in the promoter
region of target genes [8], although it was also reported that it
functioned as a nonspecific DNA-binding domain [9]. Another
member of this subfamily, PSIP1 (PC4 and SFRS1 interacting
protein 1), is a transcriptional coactivator and involved in lentiviral
integration. It was shown that the PWWP domain in PSIP1
displays affinity for DNA and chromatin and its chromatin binding
ability is crucial for the HIV-1 integration [10,11]. Recently,
PSIP1 was found to promote association of the MLL complex with
transcriptionally active chromatin through its PWWP domain
[12]. The eukaryotic mismatch repair protein MSH6 also harbors
a PWWP domain at its N-terminal region, which binds double-
stranded DNA non-specifically [13].
Alongside Tudor, chromodomain, MBT domains, the PWWP
domain belongs to the Tudor domain ‘Royal Family’ [14]. The
core of the Tudor, MBT and PWWP domains is composed of five
b-strands. The canonical chromodomain contains three b-strands
that correspond to the middle three b-strands of the Tudor, MBT
and PWWP domains, and a C-terminal a-helix. The common
function of the ‘Royal Family’ members is their ability to recognize
lysine/arginine methylated histones or proteins through an
aromatic cage [15,16,17]. Although the sequence and structure
alignments show that PWWP domains exhibits structural similarity
to other ‘Royal Family’ members and most PWWP domains also
contain an aromatic cage, it was only recently shown that PWWP
is able to bind lysine methylated histone [18,19,20,21].
In order to systematically study the structure and function of this
domain, we purified some representative human PWWP domains
and tested their binding ability to different histone peptides. The
results show that PWWP domain is a weak methyllysine histone
binder. Furthermore, we determined the crystal structures of
the PWWP domains from seven different human proteins and three
PWWP domain complex structures with histone peptides,
i.e., BRPF1-H3K36me3, HDGF2-H3K79me3 and HDGF2-
H4K20me3. Therefore, the PWWP domain can not only bind
DNA but also histones.
Results and Discussion
Structures of PWWP domains
The PWWP domain was first identified in WHSC1 and named
after the central core motif Pro-Trp-Trp-Pro of the PWWP
domain in WHSC1 [1]. The PWWP domain comprises 100–130
amine acids and is often present in chromatin-associated proteins.
In the human genome, there are at least 22 PWWP domain-
containing proteins and three of them contain 2 PWWP domains
(WHSC1, WHSC1L1, NSD1). The PWWP domains can be
categorized into 6 classes based on sequence homology (Figure 1).
The major difference between these different PWWP domains is
localized on the insertion motif, which varies in length among the
different PWWP domains.
In order to explore the functional roles of the PWWP domains,
we determined the crystal structures of the PWWP domains from 7
different human proteins, namely, BRPF1 (bromodomain and
PHD finger-containing protein 1), BRPF2, BRPF3, MUM1
(melanoma associated antigen (mutated) 1), DNMT3A, DNMT3B
and HDGF2 (Hepatoma-derived growth factor 2). Our structures
revealed that the overall fold of the PWWP domain consists of
three motifs: a canonical b-barrel core, an insertion motif between
the second and third b-strands and a C-terminal a-helix bundle
(Figure 2). The canonical b-barrel core harbors an aromatic cage
constructed by three aromatic residues, which is a signature
feature of the Tudor domain ‘‘Royal family’’ (Figure 1). MBD5
(methyl-CpG binding domain protein 5) and the N-terminal
PWWP domain of NSD1 (nuclear receptor binding SET domain
protein 1) are two exceptions, which have just one aromatic
residue at the conserved positions. A PWWP characteristic C-
terminal a helix motif is located in the C-terminal part of the
PWWP domains consisting of 1–5 a-helixes. A structure
comparison of these PWPP domains shows that the insertion
motif between the second and third b strands varies in length and
secondary structure among these different classes of PWWP
domains. This variable insertion motif is plausibly caused by
intron/exon sliding at the genomic level, as the coding region for
the second and third b strands are often split by an intron [1].
Histone binding ability of PWWP domains
The PWWP domain is structurally similar to other members in
the Tudor domain ‘Royal family’ [14], and many members in this
superfamily have been shown to bind methylated histones [15].
Furthermore, the vast majority of PWWP domains have the
aromatic residues in the conserved positions that form a putative
methyllysine binding aromatic cage (Figure 1). Therefore, it was
compelling to speculate that the PWWP domains may also exhibit
methylated histone binding ability, which was proved in recent
studies [18,19,20,21]. The Pombe protein Pdp1 harbors a PWWP
domain in its N-terminus, which was shown to bind mono-
methylated histone H4K20. Because the C-terminal fragment of
Pdp1 is able to bind the Pombe H4K20 methyltransferase SET9,
SET9 is recruited to the H4K20me1 chromatin region through
the PWWP domain of Pdp1 to increase the concentration of SET9
on chromatin and carry out the trimethylation of histone H4K20
[18]. The PWWP domains of BRPF1 and DNMT3A were
reported to bind H3K36me3 [19,20]. BRPF1 was shown to be
present on the actively transcribed gene, and its enrichment
corresponds to that of H3K36me3 [20]. DNMT3A was recruited
to the chromatin region with the H3K36me3 mark through its
interaction of the PWWP domain with H3K36me3 [19].
To better understand the histone binding ability and preference
of these human PWWP domains, we used fluorescence polariza-
tion and NMR titration techniques to measure binding affinities of
some representative PWWP domains to various histone peptides
bearing different lysine methylation states. By fluorescence
polarization assay, we found that the PWWP domains in BRPF1,
BRPF2, HDGF2, MUM1 and the N-terminal PWWP domains of
WHSC1 and WHSC1L1 show weak binding affinity to histones
with H3K36, K3K79 or H4K20 methylation (Table 1). In order
to confirm this weak histone binding, we used NMR titration to
measure the binding affinity of BRPF1 to different histone
peptides. Our NMR titration results show that BRPF1 does not
exhibit detectable binding to the H3K4me3 and H3K9me3
peptides, but binds H3K36me3 with a Kd of ,3 mM (Figure 3),
which is consistent with the results reported by Bycroft’s group
[20]. BRPF1 also shows weaker binding to H3K36me2 and
H3K79me3 peptides (Figure 3A). BRPF2 displays a binding
preference similar to BRPF1. HDGF2 binds H3K36me3,
H3K79me3 and H4K20me3 weakly (Table 1). Consistent with
the high throughput binding assay by Mann’s group, WHSC1 and
WHSC1L1 binds H3K36me3 [21]. It was reported that
DNMT3A also binds H3K36me3 [19]. Taken together, similar
to other members in the ‘Royal family’, PWWP domain also
exhibits methyllysine histone binding ability.
Structure and Function of Human PWWP Domains
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e18919Figure 1. Structure-based sequence alignment of human PWWP domains. There are over 20 PWWP containing proteins in the human
genome, which can be categorized into 6 classes. We solved crystal structures of PWWP domains from 7 different human proteins (colored in red and
boxed). The structures solved by other labs are colored in red. All of these PWWP domains contain an aromatic cage formed by three aromatic
residues (labeled by green triangles) except MBD5 and the N-terminal PWWP domain in NSD1. The identical residues in the alignment are colored in
red. The secondary structure elements of BRPF1 are shown on top of the alignment, with cylinders representing helixes and arrows representing
strands. The alignment was generated by using Clustal W assisted with manual adjustment.
doi:10.1371/journal.pone.0018919.g001
Structure and Function of Human PWWP Domains
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e18919Trimethylated lysine histone recognition by the PWWP
domains of BRPF1 and HDGF2
To shed light on the molecular mechanism of methylated
histone binding by PWWP domains, we determined the crystal
structures of the PWWP domain of human BRPF1 in complex
with H3K36me3 and that of human HDGF2 in complex with
H3K79me3 and H4K20me3.
In the BRPF1-H3K36me3 complex structure, the peptide
resides in a groove formed by the insertion motif, the fourth
b-strand and its preceding loop from the BRPF1 PWWP domain
(Figure 4A–C and Figure S1A). The trimethylated lysine K36 is
accommodated in an aromatic cage formed by three aromatic
residues (Y1096, Y1099 and F1147). Besides, histone residues
H3T32, H3G33 and H3K36me3 make several hydrogen bonds
with residues from the fourth b-strand and its preceding loop of
BRPF1 PWWP (Figure 4B). Interestingly, the H3Y41 from the
histone H3 peptide forms one side of the aromatic cage, but
mutating H3Y41 to alanine does not significantly affect the
binding of H3K36me3 peptide to BRPF1 (data not shown). We
infer that H3Y41 is not involved in the H3K36me3 recognition.
Therefore, bothe the canonical b-barrel core and the insertion
motif are directly involved in histone binding.
We were also able to co-crystallize HDGF2 with both
H3K79me3 and H4K20me3 peptides, which show very similar
binding mode. In the HDGF2-H3K79me3 complex structure
(Figure 4D–F and Figure S1B–C), the trimethylated lysine K79 is
Figure 2. Crystal structures of the seven human PWWP domains reported in this study. PWWP fold consists of three structural elements:
the canonical core (colored in cyan) comprising 5 b-strands, which highly resembles the Tudor domain fold, an insertion motif between the second
and third b strands (colored in orange) and the PWWP characteristic C-terminal a helix motif consisting of 1–5 a-helixes (colored in grey). The figure
was generated by Pymol.
doi:10.1371/journal.pone.0018919.g002
Table 1. Binding affinities of human PWWP domains for histone H3 and H4 methylated peptides.
Peptide Sequence
BRPF1
Kd(mM)
BRPF2
Kd(mM)
HDGF2
Kd(mM)
MUM1
Kd(mM)
WHSC1_N*
Kd (mM)
WHSC1L1_
N* Kd (mM)
H3K36me2 PATGGVK(me)2KPHRY 0.860.2 Very weak 1.060.2 0.460.1 0.560.1 Very weak
H3K36me3 PATGGVK(me)3KPHRY 0.860.1 0.960.1 Very weak 0.160.07 0.660.1 Very weak
H3K79me2 EIAQDFK(me)2TDLRY 0.260.01 0.260.02 Very weak ND ND ND
H3K79me3 EIAQDFK(me)3TDLRY 0.160.01 0.460.1 Very weak ND ND ND
H4K20me2 AKRHRK(me)2VLRDN Very weak ND Very weak ND ND ND
H4K20me3 AKRHRK(me)3VLRDN Very weak ND Very weak ND ND ND
*: WHSC1 and WHSC1L1 contain two PWWP domains and we only tested the N-terminal PWWP domain.
ND: not determined. Very Weak: the binding is too weak to be fitted reliably.
doi:10.1371/journal.pone.0018919.t001
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residues (Y18, W21 and F44). This trimethylated K79 is the major
contributor of the histone binding to the PWWP domain, although
histone H3 residues Q76 and D77 also make two hydrogen bonds
with V33 from the insertion motif and T50 from the fourth
b-strand of the HDGF2 PWWP domain (Figure 4E). This may
also explain why HDGF2 shows very weak binding affinity to
H3K79me3.
DNMT3A had been shown to bind histone H3K36me3 [19],
but we were not able to obtain its cocrystals with H3K36me3,
Nevertheless, we found a bis-tris buffer molecule in both the
DNMT3A and DNMT3B structures (Figure 5 and Figure S1D–
E). The propensity of the aromatic cage to bind buffer molecules
had been identified before in another ‘Royal family’ member,
L3MBTL1 [22,23]. The bis-tris molecule resides in the conserved
aromatic cage of the PWWP domains (Figure 5). Superposition of
the DNMT3A and DNMT3B with the BRPF1 and HDGF2
complex structures shows that the bis-tris molecule is bound in
the position occupied by the tri-methyl ammonium group of the
methyllysine (Figure 6). The bis-tris molecule is bound to
DNMT3A and DNMT3B in slightly different conformations. In
the DNMT3A structure, the bis-tris molecule forms two
hydrogen bonds with the D333 residue from DNMT3A, and
three hydrogen bonds with residues G298, L300 and S304
through a conserved water molecule. In the DNMT3B structure,
the bis-tris molecule forms one hydrogen bond with the D266
residue from DNMT3B, and three more hydrogen bonds with
the conserved residues G231, I233 and S237 via the conserved
Figure 3. NMR titration confirms that BRPF1 preferentially binds tri-methylated H3K36. (A) Binding affinities of the BRPF1 PWWP domain
to different histone peptides. (B)Superposition of
15N-
1H HSQC NMR spectra of the BRPF1 PWWP domain in the presence (red) and absence (blue) of
H3K79me3 (1:10) and H3K36me3 (1:10) peptides. (C) Binding affinity calculation based on the change in the chemical shifts of W1154 in the
15N-
1H
BRPF1 resonances upon addition of nonlabeled H3K36me3 peptide. (D) Binding affinity calculation based on the change in the chemical shifts of
K1092 in the
15N-
1H BRPF1 resonances upon addition of nonlabeled H3K36me3 peptide. The concentration of
15N BRPF1 in all NMR experiments is
0.2 mM. W1154 and K1092 are two residues from the BRPF1 PWWP domain.
doi:10.1371/journal.pone.0018919.g003
Structure and Function of Human PWWP Domains
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e18919water molecule. DNMT3A and DNMT3B are DNA methyl-
transferase, which are essential for de novo methylation and
mammalian development [24]. Aberrant DNA methylation is
implicated in various diseases, including cancer [25]. The current
focus of drug discovery mainly targets on the catalytic domain of
DNA methyltransferases. The bis-tris molecule in complex with
the PWWP domain of DNMT3A or DNMT3B provides a clue
for designing small molecules targeting their histone binding
domain.
In all these complex structures, the methyllysine binding
aromatic residues are from the loop between the first and second
b-strands, the N-terminus of the second b-strand and the
C-terminus of the third b-strand (Figure 1). The histone residues
C-terminal to the modified lysine do not make significant
contributions to the binding (Figure 4), reminiscent of HP1 and
Polycomb chromodomains, which mainly binds H3K9me3 and
H3K27me3 peptides through residues N-terminal to the
respective target lysines [26,27,28,29]. In these complex struc-
tures, the insertion motif is directly involved in histone binding,
forming one side of the histone binding groove (Figure 6).
Furthermore, this insertion motif has different lengths and
structures among these PWWP domains (Figure 1 and 6), which
may imply that the insertion motif plays a role in determining the
ligand specificity.
Structural comparison of the PWWP domain with the
other methyl-lysine binders
Comparison of the structural architecture of the PWWP domain
to those of chromodomain, MBT and Tudor domains shows that
PWWP, MBT and Tudor all have a 5-b-strand canonical core,
while the chromodomain consists of three b-strands and one a-
helix (Figure 7). Overall, the fold of the PWWP domain has
highest structure similarity to that of a single MBT repeat, i.e., the
b-strand core is followed by a helixes, which packs against the b
barrel core (Figure 7A and 7B). Other domains similar to PWWP
are found in Eaf3 and MRG15. Eaf3 and MRG15 bind
H3K36me3 through a chromo barrel domain [30,31,32]. This
chromo barrel domain is structurally similar to the PWWP domain
(Figure 7C), but it lacks the PWWP motif, and it harbors a small
helix turn between the third and fourth b-strands that lacks in the
PWWP domain (Figure 7C). The canonical Tudor domain
consists of five b-strands, which can overlay perfectly with the b-
barrel core of PWWP (Figure 7D). A typical chromodomain
consists of three b-strands and one a-helix, and the three b-strands
can be superimposed with the middle three b-strands of PWWP,
MBT and Tudor domains (Figure 7E and 7F).
The histone methyllysine binding mode exhibited by PWWP
is similar to that adopted by other methyllysine binding pro-
teins [23,26,27,28,29,33,34,35,36]. A common feature of these
Figure 4. Complex structures of BRPF1-H3K36me3 and HDGF2-H3K79me3. (A) Structure of BRPF1 PWWP domain in complex H3K36me3
peptide. The PWWP domain is shown in cartoon, and the peptide is shown in a stick model. (B) The detailed interactions between the BRPF1 PWWP
domain and H3K36me3. Hydrogen bonds are shown in dashed lines. (C) Electrostatic surface representation of BRPF1-H3K36me3 complex. (D)
Structure of HDGF2 PWWP domain in complex H3K79me3 peptide. The PWWP domain is shown in cartoon, and the peptide is shown in a stick
model. (E) The detailed interactions between the HDGF2 PWWP domain and H3K79me3. Hydrogen bonds are shown in dashed lines. (F) Electrostatic
surface representation of HDGF2-H3K79me3 complex.
doi:10.1371/journal.pone.0018919.g004
Structure and Function of Human PWWP Domains
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recognize the methylated lysine [15]. Nevertheless, the histone
peptides are bound to their corresponding binders in different
orientations (Figure 7G), indicating that the royal family members
do not share a common binding cleft, but a similar aromatic cage at
an almost identical position. Interestingly, histone peptides bind to a
single chromodomain as a b-strand in a position corresponding to
the first b-strand of the 5-strand canonical cores of PWWP, Tudor
and MBT domains [23,27,28,29,34,37,38] (Figure 7D).
Mutations in PWWP domain and their implications in
functions and diseases
Mutations in PWWP domain-containing proteins have been
implicated in different human diseases. The gene WHSC1 is located
in the Wolf–Hirschhorn syndrome critical region on 4p16.3 and is
disrupted by chromosomal translocation in lymphoid multiple
myeloma disease [39]. It was recently shown that BRPF2 is asso-
ciated with schizophrenia and bipolar affective disorder [40].
HDGF was reported to be involved in tumorigenesis [41] and the
PWWP domain in PSIP1 is critical for chromatin binding and the
HIV virus type 1 infectivity [10]. Mutations in MSH6 causes
inherited somatic defects in MMR and result in increased
development of hereditary non-polyposis colorectal cancer [13].
DNMT3A and DNMT3B are de novo DNA methyltransferases and
the loss-of-function mutations in human DNMT3B causes a
developmental defect characterized by hypomethylation of pericen-
tromeric repeats and are implicated in ICF (immunodeficiency,
centromeric instability, facial anomalies) syndrome [24,42]. So far,
the identified point mutations (Figure 1, residues highlighted in
yellow) that are implicated in diseases or important for functions are
all located either in the aromatic cage or on the fourth b-strand,
regions involved in histone and DNA binding.
Figure 5. PWWP domains of DNMT3A and DNMT3B bind a bis-tris molecule in their respective aromatic cage. (A) The detailed
interactions between DNMT3A and a bis-tris molecule. (B) The detailed interactions between DNMT3B and a bis-tris molecule. The bis-tris molecule is
shown in a green stick model, and the interacting residues from the PWWP domain are also shown in stick models. Hydrogen bonds are shown in
dashed lines.
doi:10.1371/journal.pone.0018919.g005
Figure 6. The peptides share a similar binding mode in the
complex structures of BRPF1-H3K36me3, HDGF2-H3K79me3
and HDGF2-H4K20me3. The bis-tris molecules in the DNMT3A/
DNMT3B complex structures are bound at the same site as the tri-
methyl-ammonium group of the methyllysine (DNMT3A structure is not
shown here for clarity). The insertion motifs from these three PWWP
domains may play a role in conferring the ligand specificity.
doi:10.1371/journal.pone.0018919.g006
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Cloning, expression and purification of human PWWP
domains
DNA fragment encoding the PWWP domain of human BRPF1
(residues 1085–1213), BRPF2 (residues 925–1049), BRPF3
(residues 1056–1195), HDGF2 (residues 1–93), DNMT3A (resi-
dues 278–427), DNMT3B (residues 206–355), MUM1 (residues
406–539) WHSC1 (residues 208–368) and WHSC1L1 (residues
247–402) were amplified by PCR and sub-cloned into pET28-
MHL vector (Genbank accession number: EF456735) and
transformed into Escherichia coli BL21 (DE3)-V2R-pRARE2. The
Figure 7. Comparison of the binding modes of methylated histone peptides to PWWP domain, chromo domain, Tudor domain and
MBT repeat domain. (A–F) Different histone code reader domains shown individually in complex with their corresponding ligands: HDGF2-
H3K36me3 (cyan, A), L3MBTL1-H4K20me2 (yellow, B), Eaf3-a mimic H3K36me2 peptide (green, C), 53BP1-H4K20me2 (red, D), CHD1-H3K4me3 (blue,
E), Polycomb-H3K27me3 (magenta, F). The peptides are shown in stick models. (G) Superposition of different histone code ‘‘reader’’ domains in
complex with their corresponding ligands. All the structures are shown in the same orientation as they are in Fig. 7A–7F. The conserved b-sheet core
among these domains is colored the same as in Fig. 7A–7F.
doi:10.1371/journal.pone.0018919.g007
Structure and Function of Human PWWP Domains
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expressed by addition of 1 mM isopropyl-1-thio-D-galactopyrano-
side (IPTG) and incubated overnight at 15uC. Harvested cells were
resuspended in 50 mM HEPES, pH 7.4, supplemented with
500 mM NaCl, 2 mM b-mercaptoethanol, 5% glycerol, 0.1%
CHAPS. The cells were lysed by passing through a microfluidizer
(Microfluidics Corporation) at 20,000 psi. After clarification of the
crude extract by high-speed centrifugation, the lysate was loaded
onto a 5 ml HiTrap chelating column (GE Healthcare), charged
with Ni
2+. The column was washed with 10 column volumes of
20 mM HEPES buffer, pH 7.4, containing 500 mM NaCl,
50 mM imidazole and 5% glycerol, the protein was eluted with
20 mM HEPES buffer, pH 7.4, 500 mM NaCl, 250 mM
imidazole, 5% glycerol. The protein was dialyzed against buffer
containing 20 mM HEPES, pH 7.4, 500 mM NaCl and 5%
glyceral. TEV protease was added to combined fractions
containing target proteins to remove the His-tag. All the proteins
except DNMT3A were further purified to homogeneity by
ion-exchange chromatography on Source 30S column (10610)
(GE Healthcare), equilibrated with 20 mM PIPES buffer, pH 6.5,
and eluted with linear gradient of NaCl up to 500 mM
concentration (20CV). For DNMT3A, Source 30Q column was
used for ion exchange chromatography. The
15N-labeled proteins
for NMR titration were purified in the same protocols as native
ones except that bacteria were grew in M9 minimal medium
containing 1 g/L
15(NH4)2SO4 as the sole nitrogen source. The
labeled proteins were concentrated to 0.15–0.3 mM for NMR
titration.
Protein crystallization
Purified PWWP domain proteins were crystallized using
hanging drop vapor diffusion method at 20uC by mixing 1 mlo f
Table 2. Crystallography data and refinement statistics.
BRPF1 BRPF1+H3K36me3 BRPF2 BRPF3 HDGF2+H4K20me3
PDB Code 3L42 3MO8 3LYI 3PFS 3QBY
Data collection
Space group P43212 I222 P212121 P21212P 2 12121
Cell dimensions
a, b, c (A ˚) 44.35, 44.35, 122.72 43.09, 70.61, 113.54 45.03, 46.08, 130.71 68.41,134.52,30.23 41.53, 41.68, 156.75
a, b,c (u) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (A ˚) (highest
resolution shell)
40.00-1.30
(1.32-1.30)
50.0 – 1.70
(1.74-1.70)
50.0 – 2.10
(2.18 – 2.10)
50.00-1.90
(1.97-1.90)
25.00-1.94
(1.97-1.94)
Unique reflections 31403 19545 16475 22879 21026
Rmerge 5.6 (46.5) 6.2 (40.7) 7.4 (49.5) 9.1 (47.6) 3.9 (18.2)
,I./,s(I). 65.7 (7.9) 30.0 (3.5) 24.6 (3.2) 9.5(4.6) 58.7 (9.2)
Completeness (%) 99.9 (100.0) 99.4 (96.7) 99.0 (95.3) 99.9 (100.0) 99.9 (98.3)
Redundancy 14.5 (13.8) 7.7 (6.0) 6.7 (5.0) 6.0 (6.0) 6.4 (5.4)
Refinement
Resolution (A ˚) 30.00-1.30 60.0-1.70 37.7 – 2.10 67.3-1.90 20.00-1.95
No. reflections (of
which test set)
31089 (1565) 18540 (1005) 15594 (827) 21660(1170) 20561 (1055)
Rwork/Rfree (%) 20.9/23.3 19.2/20.7 23.4/27.6 21.3/25.9 21.6/25.3
No. atoms
Protein 1056 1041 1802 2099 2021
Ligand 0 96 0 0 22
Water 109 107 78 136 52
B-factors (A ˚2)
Protein 13.1 20.1 43.4 17.0 34.5
Ligand N/A 22.7 N/A N/A 53.9
Water 20.2 28.8 46.7 25.2 36.9
R.m.s deviations
Bond lengths (A ˚) 0.016 0.011 0.012 0.011 0.011
Bond angles (u) 1.63 1.21 1.36 1.20 1.21
Ramachandran
plot % residues
Favored 95.3 94.6 93.7 98.1 93.7
Additionally allowed 4.7 5.4 6.3 1.9 6.3
Generously allowed 0.0 0.0 0.0 0.0 0.0
Disallowed 0.0 0.0 0.0 0.0 0.0
doi:10.1371/journal.pone.0018919.t002
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solution. BRPF1 (apo) and its complex with H3K36me3 peptide
were crystallized in 3.5 M sodium formate, 0.1 M Tris-HCl,
pH 8.5; BRPF2 in 30% PEG2K-MME, 0.20 M potassium
bromide; BRPF3 in 30% PEG 4,000, 0.2 M ammonium sulfate,
0.1 M sodium cacodylate, pH 6.5; HDGF2 in 2.0 M ammoni-
um sulfate, 0.2 M potassium/sodium tartrate, 0.1 M sodium
citrate pH 5.6; HDGF2-H3K79me3 complex in 2.0 M ammo-
nium sulfate, 5% isopropanol; MUM1 in 25% PEG 3,350,
0.1 M ammonium sulfate, 0.1 M HEPES, pH 7.5; DNMT3A in
28% PEG 3,350, 0.1 M ammonium sulfate, 0.1 M Bis-Tris,
pH 6.0; DNMT3B in 30% PEG2K-MME, 0.20 M potassium
bromide, 0.1 M Bis-Tris, pH 6.5. The peptides used for co-
crystallization are: SAPATGGVKme3KPHRYR (H3K36me3);
EIAQDFK(me)3TDLRY (H3K79me3); AKRHRKme3VLRDN
(H4K20me3).
Fluorescence polarization assay
Fluorescence polarization assays were performed in 384-well plates,
using the Synergy 2 microplate reader from BioTek as described in
[43]. All the peptides were synthesized and purified by Tufts
University Core Services (Boston, MA, U.S.A.), with the N-terminus
labeled with fluorescein. Binding assays were performed in a 10 ml
volume at a constant labeled peptide concentration (40 nM), by
titrating the PWWP domains (at concentrations ranging from low to
high micromolar) into 20 mM PIPES buffer (pH 6.5), containing
50 mM NaCl, 0.01% Tween-20. The data points were fitted to ligand
binding function using Sigma Plot software to determine the Kdvalues.
Table 3. Crystallography data and refinement statistics.
HGDF2 HDGF2+H3K79me3 MUM1 DNMT3A DNMT3B
PDB Code 3EAE 3QJ6 3PMI 3LLR 3QKJ
Data collection
Space group P212121 P61 P212121 P21 P32
Cell dimensions
a, b, c (A ˚) 41.56, 59.95, 104.94 74.93, 74.93, 41.76 55.04, 57.72, 187.07 67.11, 83.99, 74.59 74.54, 74.54 160.27
a, b,c (u) 90, 90, 90 90, 90, 120 90, 90, 90 90, 90.48, 90 90, 90, 120
Resolution (A ˚) (highest
resolution shell)
40.00-2.25
(2.33-2.25)
40.00-2.30
(2.34-2.30)
50.0-2.85
(2.95-2.85)
50.00-2.30
(2.40-2.30)
50.0 – 2.05
(2.11 – 2.04)
Unique reflections 12838 6094 14914 36557 62131
Rmerge 8.2 (56.5) 8.5 (46.6) 0.110 (52.2) 10.9(34.6) 7.1 (60.6)
,I./,s(I). 24.4 (2.3) 43.9 (6.2) 17.5 (3.9) 12.4(4.2) 12.3 (2.0)
Completeness (%) 96.7 (83.5) 100.0 (100.0) 99.9 (100.0) 99.0(98.5) 98.9 (97.8)
Redundancy 6.4 (4.6) 10.8 (10.4) 6.8 (7.1) 3.8(3.8) 3.6 (3.4)
Refinement
Resolution (A ˚) 40.00-2.24 37.47-2.30 50.0-2.82 50.10-2.30 34.04-2.04
No. reflections (of which test set) 12148 (632) 6063 (281) 14110 (751) 34711 (1819) 59117 (3163)
Rwork/Rfree (%) 22.4/26.0 23.4/27.6 22.8/30.4 22.4/25.9 22.6/27.1
No. atoms
Protein 1322 719 3797 5373 4200
Ligand 0 45 0 70 56
Water 45 10 0 362 321
B-factors (A ˚2)
Protein 53.1 42.0 18.5 15.4 49.6
Ligand N/A 46.7 N/A 26.9 57.4
Water 51.0 32.3 N/A 20.9 56.4
R.m.s deviations
Bond lengths (A ˚) 0.012 0.011 0.011 0.006 0.023
Bond angles (u) 1.26 1.17 1.29 0.95 1.90
Ramachandran plot % residues
Favored 95.3 91.5 90.3 96.9 95.7
Additionally allowed 4.7 8.5 9.0 1.5 3.2
Generously allowed 0.0 0.0 0.7 1.6 1.2
Disallowed 0.0 0.0 0.0 0.0 0.0
*: Values in parentheses correspond to the highest resolution shells.
#Rmerge=ShklSjDI(hkl;j)2,I(hkl).|/(ShklSj,I(hkl).), where I(hkl;j) is the jth measurement of the intensity of the unique reflection (hkl), and I(hkl) is the mean overall
symmetry related measurements.
1RMSD: root mean squared deviation.
doi:10.1371/journal.pone.0018919.t003
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To map the binding site of BRPF1 and HDGF2 PWWP domain
for various methylated histone peptides and estimate the corre-
sponding Kds,
15N-
1H HSQC spectra were collected with
15N-labeled samples of PWWP domains, free and with additions
ofincreasingamounts ofunlabeled H3K4me3 (1–11aa),H3K9me3
(1–15 aa), H3K36me3 (30–41 aa), H3K79me3 (73–84 aa),
p53K370me2 (365–375 aa), p53K372me2 (364–376 aa) and
p53K382me2 (376–388 aa) peptides. Weighted average chemical
shift variations (D ppm) were calculated according to the formula
(D ppm=([dH
N]
2+[dN]
2)
K, where dH
N and dN are the changes in
HN and N chemical shifts, respectively) as described in [30]. From
the Dppm, the Kds were estimated with the amide peaks of two
selected amino acids, as shown in Figure 4. The shifted BRPF1
resonances are assigned according to the recent publication [20].
Data Collection and Structure Determination
All diffraction data were collected at 100 K and reduced with
the HKL suite of programs [44]. To obtain phase information for
BRPF1, 436 0.5u oscillation images collected on an FR-E copper
rotating anode source (Rigaku) on a selenomethionyl derivative
[45] crystal of space group I222 (a=43.3 A ˚, b=72.0 A ˚,
c=114.0 A ˚). The structure was solved with the single wavelength
anomalous diffraction (SAD) method [46] using the programs
SHELXD and SHELXE [47]. An initial model was build
automatically with the program ARP/wARP [48]. The model
was further refined against a dataset that was derived from 406
0.5u oscillation images collected at beamline 19ID of the
Advanced Photon Source at a wavelength of 0.977 A ˚. COOT
[49], REFMAC [50], and MOLPROBITY [51] were used for
interactive model building, refinement and validation, respectively.
The crystal structures of DNMT3A, DNMT3B, BRPF2, BRPF3,
MUM1 and the complex structures of BRPF1-H3K36me3,
HDGF2-H3K79me3 and HDGF2-H4K20me3 were solved by
molecular replacement using MOLREP [52], and refined using a
similar protocol to that of apo-BRPF1. Crystal diffraction data and
refinement statistics are displayed in Tables 2 and 3.
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2Fo-Fc density map for the bis-tris molecule in the DNMT3B-bis-
tris structure.
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